Noxafil
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Les medicaments sont indispensables pour la sante mais leur usage n’est pas anodin. Les indications autorisees du dossier d’AMM d…
Solid-state NMR (ssNMR) spectroscopy has shown its indispensable capability of elucidating atomic level structures and…
Objectives: Compare the cost of the primary prophylaxis of invasive fungal infections (IFI) with voriconazole, posaconazole, and…
The incidence of fungal infections has dramatically increased in the past few decades.1,2 These infections contribute…
Noxafil oral suspension, a new antifungal agent from Schering-Plough Corp., received marketing approval for the prevention of…
Posaconazole [SCH 56592, SPRIAFIL, Noxafil] is an orally active triazole derivative that is in phase III trials with the Schering…